Zdrowie i gospodarka · 22/05/2018
FDA Establishes Public Docket for Assessing pH-Dependent Drug-Drug Interactions
The FDA is seeking public input on best practices for assessing pH-dependent drug-drug interactions, following the publication of two draft guidance documents in 2017.
Source: Federal Register — Food and Drug AdministrationOpen original release →